Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. CME
CME logo

CME Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy CME Group Inc (CME) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
294.000
1 Day change
-1.20%
52 Week Range
329.160
Analysis Updated At
2026/03/27
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

CME Group Inc is not a strong buy at the moment for a beginner investor with a long-term horizon. While the company has shown strong financial performance in the latest quarter and has positive growth potential, the technical indicators suggest a neutral to slightly bearish trend. Additionally, the options data reflects bearish sentiment, and there are no immediate catalysts to drive significant upward momentum. A hold position is recommended until clearer bullish signals emerge.

Technical Analysis

The MACD histogram is negative and expanding, indicating bearish momentum. RSI is neutral at 31.048, and moving averages are converging, suggesting indecision in the market. The stock is trading near its S1 support level of 296.35, with resistance at 305.441. Overall, the technical indicators do not signal a strong buy opportunity.

Options Data

Bearish
Open Interest Put-Call Ratio
Bearish
Option Volume Put-Call Ratio

The high Put-Call Ratios indicate bearish sentiment in the options market, with significantly higher put volume compared to call volume.

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
10
Buy
5

Positive Catalysts

  • Strong financial performance in Q4 2025, with revenue up 26.71% YoY, net income up 35.23% YoY, and EPS up 35.00% YoY. Analysts have raised price targets recently, citing growth potential in new initiatives like prediction markets and tokenization.

Neutral/Negative Catalysts

  • Recent legislative proposals targeting prediction markets could negatively impact CME's growth in this area. Options data reflects bearish sentiment, and technical indicators suggest a lack of bullish momentum. Analysts have also expressed concerns about muted growth in certain segments like equity index and crypto.

Financial Performance

In Q4 2025, CME Group reported a 26.71% YoY increase in revenue, a 35.23% YoY increase in net income, and a 35.00% YoY increase in EPS. These results highlight strong growth trends, supported by elevated trading volumes and new initiatives.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Analyst ratings are mixed. While some firms have raised price targets and maintained Buy ratings, others have downgraded the stock to Hold, citing concerns about muted growth in certain segments. The most recent upgrade was from Erste Group, which upgraded CME to Buy from Hold.

Wall Street analysts forecast CME stock price to fall
10 Analyst Rating
Wall Street analysts forecast CME stock price to fall
4 Buy
4 Hold
2 Sell
Hold
Current: 297.580
sliders
Low
209
Averages
285.9
High
320
Current: 297.580
sliders
Low
209
Averages
285.9
High
320
Erste Group
Hans Engel
Hold
to
Buy
upgrade
AI Analysis
2026-03-05
Reason
Erste Group
Hans Engel
Price Target
AI Analysis
2026-03-05
upgrade
Hold
to
Buy
Reason
Erste Group analyst Hans Engel upgraded CME Group to Buy from Hold.
Argus
Buy
to
Hold
downgrade
2026-03-04
Reason
Argus
Price Target
2026-03-04
downgrade
Buy
to
Hold
Reason
Argus downgraded CME Group to Hold from Buy.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for CME
Unlock Now

People Also Watch